Novartis AG (MEX:NVS N) Future 3-5Y EPS without NRI Growth Rate : 13.32 (As of Apr. 24, 2025)

View and export this data going back to 2008. Start your Free Trial

What is Novartis AG Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Novartis AG's Future 3-5Y EPS without NRI Growth Rate is 13.32.

Competitive Comparison of Novartis AG's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - General subindustry, Novartis AG's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novartis AG's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Novartis AG's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Novartis AG (MEX:NVS N) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Novartis AG Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Novartis AG's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (MEX:NVS N) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS:USA NOVN:Mexico NOVNz:UK 0K9E:UK 0QLR:UK NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland NVS:Canada N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines